The Living Guidelines: Patients at High Risk for Developing Heart Failure. Polling Results for CLASS IIa Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class IIa Guidelines
1. Angiotensin converting enzyme inhibitors can be useful to prevent HF in patients at high risk for developing HF who have a history of atherosclerotic vascular disease, diabetes mellitus, or hypertension with associated cardiovascular risk factors. (Level of Evidence: A)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 1 for patients at high risk for developing heart failure should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. Angiotensin II receptor blockers can be useful to prevent HF in patients at high risk for developing HF who have a history of atherosclerotic vascular disease, diabetes mellitus, or hypertension with associated cardiovascular risk factors. (Level of Evidence: C)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class IIa Recommendation 2 for patients at high risk for developing heart failure should be: CLASS I CLASS IIa CLASS IIb CLASS III